nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—ovarian cancer	0.771	1	CbGaD
Raltitrexed—FPGS—myometrium—ovarian cancer	0.00548	0.121	CbGeAlD
Raltitrexed—FPGS—decidua—ovarian cancer	0.00406	0.0897	CbGeAlD
Raltitrexed—FPGS—endometrium—ovarian cancer	0.00386	0.0851	CbGeAlD
Raltitrexed—FPGS—female reproductive system—ovarian cancer	0.00319	0.0705	CbGeAlD
Raltitrexed—FPGS—female gonad—ovarian cancer	0.00291	0.0642	CbGeAlD
Raltitrexed—FPGS—vagina—ovarian cancer	0.00289	0.0638	CbGeAlD
Raltitrexed—TYMS—uterine cervix—ovarian cancer	0.0028	0.0617	CbGeAlD
Raltitrexed—Methotrexate—FOLR1—ovarian cancer	0.00259	0.374	CrCbGaD
Raltitrexed—FPGS—testis—ovarian cancer	0.00258	0.0569	CbGeAlD
Raltitrexed—TYMS—endometrium—ovarian cancer	0.00253	0.0558	CbGeAlD
Raltitrexed—TYMS—gonad—ovarian cancer	0.00235	0.0518	CbGeAlD
Raltitrexed—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.00225	0.472	CbGdCrCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00222	0.0599	CbGpPWpGaD
Raltitrexed—TYMS—female reproductive system—ovarian cancer	0.0021	0.0463	CbGeAlD
Raltitrexed—TYMS—bone marrow—ovarian cancer	0.00198	0.0437	CbGeAlD
Raltitrexed—TYMS—female gonad—ovarian cancer	0.00191	0.0421	CbGeAlD
Raltitrexed—TYMS—vagina—ovarian cancer	0.00189	0.0418	CbGeAlD
Raltitrexed—FPGS—lymph node—ovarian cancer	0.00187	0.0413	CbGeAlD
Raltitrexed—TYMS—Nucleotide metabolism—NME2—ovarian cancer	0.00179	0.0484	CbGpPWpGaD
Raltitrexed—TYMS—testis—ovarian cancer	0.00169	0.0373	CbGeAlD
Raltitrexed—TYMS—G1/S-Specific Transcription—CCNE1—ovarian cancer	0.0014	0.0378	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—FASN—ovarian cancer	0.00139	0.0375	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—ovarian cancer	0.00132	0.0356	CbGpPWpGaD
Raltitrexed—Leucovorin—TYMS—ovarian cancer	0.00129	0.187	CrCbGaD
Raltitrexed—Pralatrexate—TYMS—ovarian cancer	0.00129	0.187	CrCbGaD
Raltitrexed—TYMS—lymph node—ovarian cancer	0.00123	0.0271	CbGeAlD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00116	0.0312	CbGpPWpGaD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.00112	0.236	CbGdCrCtD
Raltitrexed—Pemetrexed—TYMS—ovarian cancer	0.00103	0.149	CrCbGaD
Raltitrexed—TYMS—E2F transcription factor network—RBL2—ovarian cancer	0.000977	0.0264	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—PPP2R1A—ovarian cancer	0.000887	0.024	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—CCNE1—ovarian cancer	0.000823	0.0222	CbGpPWpGaD
Raltitrexed—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000772	0.162	CbGdCrCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000736	0.0199	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000692	0.0187	CbGpPWpGaD
Raltitrexed—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.000621	0.13	CbGdCrCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000597	0.0161	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HSD17B6—ovarian cancer	0.000583	0.0157	CbGpPWpGaD
Raltitrexed—Methotrexate—TYMS—ovarian cancer	0.000569	0.0823	CrCbGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000565	0.0153	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000564	0.0152	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TOP1—ovarian cancer	0.000541	0.0146	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—BRCA1—ovarian cancer	0.000498	0.0135	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000473	0.0128	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—SKP2—ovarian cancer	0.000472	0.0127	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CHMP4C—ovarian cancer	0.000466	0.0126	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RSF1—ovarian cancer	0.000465	0.0126	CbGpPWpGaD
Raltitrexed—Cough—Topotecan—ovarian cancer	0.000453	0.00335	CcSEcCtD
Raltitrexed—Alopecia—Vinorelbine—ovarian cancer	0.000451	0.00333	CcSEcCtD
Raltitrexed—Extravasation—Epirubicin—ovarian cancer	0.000448	0.00331	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NME2—ovarian cancer	0.000446	0.0121	CbGpPWpGaD
Raltitrexed—Atrial fibrillation—Docetaxel—ovarian cancer	0.000444	0.00328	CcSEcCtD
Raltitrexed—Cough—Melphalan—ovarian cancer	0.000443	0.00328	CcSEcCtD
Raltitrexed—Arthralgia—Topotecan—ovarian cancer	0.000442	0.00326	CcSEcCtD
Raltitrexed—Renal impairment—Docetaxel—ovarian cancer	0.000442	0.00326	CcSEcCtD
Raltitrexed—Discomfort—Topotecan—ovarian cancer	0.000437	0.00323	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CCNE1—ovarian cancer	0.000436	0.0118	CbGpPWpGaD
Raltitrexed—Cellulitis—Epirubicin—ovarian cancer	0.000429	0.00317	CcSEcCtD
Raltitrexed—Infection—Topotecan—ovarian cancer	0.000421	0.00311	CcSEcCtD
Raltitrexed—Dyspepsia—Chlorambucil—ovarian cancer	0.000419	0.00309	CcSEcCtD
Raltitrexed—Oedema—Melphalan—ovarian cancer	0.000415	0.00306	CcSEcCtD
Raltitrexed—Thrombocytopenia—Topotecan—ovarian cancer	0.000415	0.00306	CcSEcCtD
Raltitrexed—Extravasation—Doxorubicin—ovarian cancer	0.000414	0.00306	CcSEcCtD
Raltitrexed—Decreased appetite—Chlorambucil—ovarian cancer	0.000414	0.00306	CcSEcCtD
Raltitrexed—Infection—Melphalan—ovarian cancer	0.000412	0.00304	CcSEcCtD
Raltitrexed—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000412	0.00304	CcSEcCtD
Raltitrexed—Anaemia—Vinorelbine—ovarian cancer	0.00041	0.00303	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—HNF1B—ovarian cancer	0.00041	0.0111	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Topotecan—ovarian cancer	0.000409	0.00303	CcSEcCtD
Raltitrexed—Pain—Chlorambucil—ovarian cancer	0.000407	0.00301	CcSEcCtD
Raltitrexed—Thrombocytopenia—Melphalan—ovarian cancer	0.000406	0.003	CcSEcCtD
Raltitrexed—FPGS—Disease—BCL9—ovarian cancer	0.000404	0.0109	CbGpPWpGaD
Raltitrexed—Anorexia—Topotecan—ovarian cancer	0.000404	0.00298	CcSEcCtD
Raltitrexed—Neutropenia—Paclitaxel—ovarian cancer	0.000401	0.00296	CcSEcCtD
Raltitrexed—Malaise—Vinorelbine—ovarian cancer	0.0004	0.00296	CcSEcCtD
Raltitrexed—Leukopenia—Vinorelbine—ovarian cancer	0.000397	0.00294	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000397	0.0107	CbGpPWpGaD
Raltitrexed—Cellulitis—Doxorubicin—ovarian cancer	0.000397	0.00294	CcSEcCtD
Raltitrexed—Anorexia—Melphalan—ovarian cancer	0.000395	0.00292	CcSEcCtD
Raltitrexed—Feeling abnormal—Chlorambucil—ovarian cancer	0.000392	0.0029	CcSEcCtD
Raltitrexed—Dehydration—Docetaxel—ovarian cancer	0.000391	0.00289	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000389	0.00287	CcSEcCtD
Raltitrexed—Weight decreased—Paclitaxel—ovarian cancer	0.000388	0.00286	CcSEcCtD
Raltitrexed—Cough—Vinorelbine—ovarian cancer	0.000387	0.00286	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000386	0.00285	CcSEcCtD
Raltitrexed—Influenza like illness—Epirubicin—ovarian cancer	0.000379	0.0028	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000379	0.0102	CbGpPWpGaD
Raltitrexed—Arthralgia—Vinorelbine—ovarian cancer	0.000378	0.00279	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000378	0.00279	CcSEcCtD
Raltitrexed—Abdominal pain—Chlorambucil—ovarian cancer	0.000376	0.00278	CcSEcCtD
Raltitrexed—Body temperature increased—Chlorambucil—ovarian cancer	0.000376	0.00278	CcSEcCtD
Raltitrexed—Renal failure—Paclitaxel—ovarian cancer	0.000376	0.00278	CcSEcCtD
Raltitrexed—Discomfort—Vinorelbine—ovarian cancer	0.000373	0.00276	CcSEcCtD
Raltitrexed—Skin exfoliation—Epirubicin—ovarian cancer	0.000373	0.00275	CcSEcCtD
Raltitrexed—Dyspepsia—Topotecan—ovarian cancer	0.000373	0.00275	CcSEcCtD
Raltitrexed—Stomatitis—Paclitaxel—ovarian cancer	0.000372	0.00275	CcSEcCtD
Raltitrexed—Conjunctivitis—Paclitaxel—ovarian cancer	0.000371	0.00274	CcSEcCtD
Raltitrexed—Decreased appetite—Topotecan—ovarian cancer	0.000368	0.00272	CcSEcCtD
Raltitrexed—Dyspepsia—Melphalan—ovarian cancer	0.000365	0.0027	CcSEcCtD
Raltitrexed—Pain—Topotecan—ovarian cancer	0.000362	0.00268	CcSEcCtD
Raltitrexed—Constipation—Topotecan—ovarian cancer	0.000362	0.00268	CcSEcCtD
Raltitrexed—Decreased appetite—Melphalan—ovarian cancer	0.000361	0.00266	CcSEcCtD
Raltitrexed—Infection—Vinorelbine—ovarian cancer	0.00036	0.00266	CcSEcCtD
Raltitrexed—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000355	0.00262	CcSEcCtD
Raltitrexed—Pain—Melphalan—ovarian cancer	0.000355	0.00262	CcSEcCtD
Raltitrexed—Mouth ulceration—Epirubicin—ovarian cancer	0.000353	0.00261	CcSEcCtD
Raltitrexed—Influenza like illness—Doxorubicin—ovarian cancer	0.000351	0.00259	CcSEcCtD
Raltitrexed—Feeling abnormal—Topotecan—ovarian cancer	0.000349	0.00258	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Topotecan—ovarian cancer	0.000346	0.00256	CcSEcCtD
Raltitrexed—Anorexia—Vinorelbine—ovarian cancer	0.000345	0.00255	CcSEcCtD
Raltitrexed—Skin exfoliation—Doxorubicin—ovarian cancer	0.000345	0.00255	CcSEcCtD
Raltitrexed—Hypertonia—Epirubicin—ovarian cancer	0.000342	0.00253	CcSEcCtD
Raltitrexed—Asthenia—Chlorambucil—ovarian cancer	0.000341	0.00252	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—PPP2R1A—ovarian cancer	0.000341	0.00921	CbGpPWpGaD
Raltitrexed—Neutropenia—Docetaxel—ovarian cancer	0.00034	0.00251	CcSEcCtD
Raltitrexed—Sepsis—Epirubicin—ovarian cancer	0.000339	0.0025	CcSEcCtD
Raltitrexed—Pruritus—Chlorambucil—ovarian cancer	0.000337	0.00249	CcSEcCtD
Raltitrexed—Body temperature increased—Topotecan—ovarian cancer	0.000335	0.00247	CcSEcCtD
Raltitrexed—Abdominal pain—Topotecan—ovarian cancer	0.000335	0.00247	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00033	0.00244	CcSEcCtD
Raltitrexed—Weight decreased—Docetaxel—ovarian cancer	0.000329	0.00243	CcSEcCtD
Raltitrexed—Mouth ulceration—Doxorubicin—ovarian cancer	0.000327	0.00241	CcSEcCtD
Raltitrexed—Diarrhoea—Chlorambucil—ovarian cancer	0.000326	0.00241	CcSEcCtD
Raltitrexed—Renal failure—Docetaxel—ovarian cancer	0.000318	0.00235	CcSEcCtD
Raltitrexed—Hypertonia—Doxorubicin—ovarian cancer	0.000317	0.00234	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—CCNE1—ovarian cancer	0.000317	0.00855	CbGpPWpGaD
Raltitrexed—Stomatitis—Docetaxel—ovarian cancer	0.000316	0.00233	CcSEcCtD
Raltitrexed—Hepatic failure—Epirubicin—ovarian cancer	0.000315	0.00233	CcSEcCtD
Raltitrexed—Decreased appetite—Vinorelbine—ovarian cancer	0.000315	0.00233	CcSEcCtD
Raltitrexed—Conjunctivitis—Docetaxel—ovarian cancer	0.000315	0.00233	CcSEcCtD
Raltitrexed—Sepsis—Doxorubicin—ovarian cancer	0.000314	0.00232	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000313	0.00231	CcSEcCtD
Raltitrexed—Pain—Vinorelbine—ovarian cancer	0.00031	0.00229	CcSEcCtD
Raltitrexed—Constipation—Vinorelbine—ovarian cancer	0.00031	0.00229	CcSEcCtD
Raltitrexed—Arrhythmia—Paclitaxel—ovarian cancer	0.000306	0.00226	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000305	0.00823	CbGpPWpGaD
Raltitrexed—Asthenia—Topotecan—ovarian cancer	0.000304	0.00225	CcSEcCtD
Raltitrexed—Alopecia—Paclitaxel—ovarian cancer	0.000303	0.00224	CcSEcCtD
Raltitrexed—Vomiting—Chlorambucil—ovarian cancer	0.000303	0.00224	CcSEcCtD
Raltitrexed—FPGS—Disease—PPP1CC—ovarian cancer	0.0003	0.00811	CbGpPWpGaD
Raltitrexed—Pruritus—Topotecan—ovarian cancer	0.0003	0.00221	CcSEcCtD
Raltitrexed—Feeling abnormal—Vinorelbine—ovarian cancer	0.000299	0.00221	CcSEcCtD
Raltitrexed—Renal impairment—Epirubicin—ovarian cancer	0.000298	0.0022	CcSEcCtD
Raltitrexed—Asthenia—Melphalan—ovarian cancer	0.000298	0.0022	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000296	0.00219	CcSEcCtD
Raltitrexed—Pruritus—Melphalan—ovarian cancer	0.000293	0.00217	CcSEcCtD
Raltitrexed—Dysgeusia—Paclitaxel—ovarian cancer	0.000292	0.00216	CcSEcCtD
Raltitrexed—Hepatic failure—Doxorubicin—ovarian cancer	0.000292	0.00216	CcSEcCtD
Raltitrexed—Diarrhoea—Topotecan—ovarian cancer	0.00029	0.00214	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000289	0.00214	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYTB—ovarian cancer	0.000288	0.00777	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000287	0.00776	CbGpPWpGaD
Raltitrexed—Abdominal pain—Vinorelbine—ovarian cancer	0.000286	0.00212	CcSEcCtD
Raltitrexed—Body temperature increased—Vinorelbine—ovarian cancer	0.000286	0.00212	CcSEcCtD
Raltitrexed—Diarrhoea—Melphalan—ovarian cancer	0.000284	0.0021	CcSEcCtD
Raltitrexed—Nausea—Chlorambucil—ovarian cancer	0.000283	0.00209	CcSEcCtD
Raltitrexed—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000277	0.00205	CcSEcCtD
Raltitrexed—Anaemia—Paclitaxel—ovarian cancer	0.000276	0.00204	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—ovarian cancer	0.000276	0.00204	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000269	0.00728	CbGpPWpGaD
Raltitrexed—Vomiting—Topotecan—ovarian cancer	0.000269	0.00199	CcSEcCtD
Raltitrexed—Malaise—Paclitaxel—ovarian cancer	0.000269	0.00199	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000268	0.00725	CbGpPWpGaD
Raltitrexed—Leukopenia—Paclitaxel—ovarian cancer	0.000267	0.00197	CcSEcCtD
Raltitrexed—Rash—Topotecan—ovarian cancer	0.000267	0.00197	CcSEcCtD
Raltitrexed—Dermatitis—Topotecan—ovarian cancer	0.000267	0.00197	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000267	0.00721	CbGpPWpGaD
Raltitrexed—Headache—Topotecan—ovarian cancer	0.000265	0.00196	CcSEcCtD
Raltitrexed—Vomiting—Melphalan—ovarian cancer	0.000264	0.00195	CcSEcCtD
Raltitrexed—Dehydration—Epirubicin—ovarian cancer	0.000264	0.00195	CcSEcCtD
Raltitrexed—Rash—Melphalan—ovarian cancer	0.000261	0.00193	CcSEcCtD
Raltitrexed—Dermatitis—Melphalan—ovarian cancer	0.000261	0.00193	CcSEcCtD
Raltitrexed—Cough—Paclitaxel—ovarian cancer	0.000261	0.00193	CcSEcCtD
Raltitrexed—Asthenia—Vinorelbine—ovarian cancer	0.00026	0.00192	CcSEcCtD
Raltitrexed—Arrhythmia—Docetaxel—ovarian cancer	0.00026	0.00192	CcSEcCtD
Raltitrexed—Alopecia—Docetaxel—ovarian cancer	0.000257	0.0019	CcSEcCtD
Raltitrexed—Pruritus—Vinorelbine—ovarian cancer	0.000256	0.00189	CcSEcCtD
Raltitrexed—Arthralgia—Paclitaxel—ovarian cancer	0.000254	0.00188	CcSEcCtD
Raltitrexed—Nausea—Topotecan—ovarian cancer	0.000252	0.00186	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PPP1CC—ovarian cancer	0.000251	0.00679	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—BRIP1—ovarian cancer	0.000251	0.00679	CbGpPWpGaD
Raltitrexed—Discomfort—Paclitaxel—ovarian cancer	0.000251	0.00186	CcSEcCtD
Raltitrexed—Diarrhoea—Vinorelbine—ovarian cancer	0.000248	0.00183	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—ovarian cancer	0.000248	0.00183	CcSEcCtD
Raltitrexed—Nausea—Melphalan—ovarian cancer	0.000246	0.00182	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000246	0.00665	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RAD51C—ovarian cancer	0.000244	0.00659	CbGpPWpGaD
Raltitrexed—Dehydration—Doxorubicin—ovarian cancer	0.000244	0.0018	CcSEcCtD
Raltitrexed—Oedema—Paclitaxel—ovarian cancer	0.000244	0.0018	CcSEcCtD
Raltitrexed—Infection—Paclitaxel—ovarian cancer	0.000242	0.00179	CcSEcCtD
Raltitrexed—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000239	0.00176	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000239	0.00645	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000236	0.00174	CcSEcCtD
Raltitrexed—Anaemia—Docetaxel—ovarian cancer	0.000234	0.00173	CcSEcCtD
Raltitrexed—Anorexia—Paclitaxel—ovarian cancer	0.000232	0.00172	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000231	0.00623	CbGpPWpGaD
Raltitrexed—Vomiting—Vinorelbine—ovarian cancer	0.00023	0.0017	CcSEcCtD
Raltitrexed—Neutropenia—Epirubicin—ovarian cancer	0.000229	0.00169	CcSEcCtD
Raltitrexed—Rash—Vinorelbine—ovarian cancer	0.000228	0.00169	CcSEcCtD
Raltitrexed—Dermatitis—Vinorelbine—ovarian cancer	0.000228	0.00169	CcSEcCtD
Raltitrexed—FPGS—Disease—HDAC6—ovarian cancer	0.000228	0.00615	CbGpPWpGaD
Raltitrexed—Headache—Vinorelbine—ovarian cancer	0.000227	0.00168	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—ovarian cancer	0.000227	0.00167	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1B—ovarian cancer	0.000226	0.00611	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000222	0.00164	CcSEcCtD
Raltitrexed—Weight decreased—Epirubicin—ovarian cancer	0.000222	0.00164	CcSEcCtD
Raltitrexed—Cough—Docetaxel—ovarian cancer	0.000221	0.00163	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000219	0.00592	CbGpPWpGaD
Raltitrexed—Arthralgia—Docetaxel—ovarian cancer	0.000215	0.00159	CcSEcCtD
Raltitrexed—Nausea—Vinorelbine—ovarian cancer	0.000215	0.00159	CcSEcCtD
Raltitrexed—Renal failure—Epirubicin—ovarian cancer	0.000215	0.00159	CcSEcCtD
Raltitrexed—Dyspepsia—Paclitaxel—ovarian cancer	0.000215	0.00158	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—PPP1CC—ovarian cancer	0.000213	0.00576	CbGpPWpGaD
Raltitrexed—Stomatitis—Epirubicin—ovarian cancer	0.000213	0.00157	CcSEcCtD
Raltitrexed—Conjunctivitis—Epirubicin—ovarian cancer	0.000212	0.00157	CcSEcCtD
Raltitrexed—Neutropenia—Doxorubicin—ovarian cancer	0.000212	0.00157	CcSEcCtD
Raltitrexed—Decreased appetite—Paclitaxel—ovarian cancer	0.000212	0.00157	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—ovarian cancer	0.000209	0.00155	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000209	0.00564	CbGpPWpGaD
Raltitrexed—Constipation—Paclitaxel—ovarian cancer	0.000208	0.00154	CcSEcCtD
Raltitrexed—Pain—Paclitaxel—ovarian cancer	0.000208	0.00154	CcSEcCtD
Raltitrexed—Oedema—Docetaxel—ovarian cancer	0.000207	0.00153	CcSEcCtD
Raltitrexed—Infection—Docetaxel—ovarian cancer	0.000205	0.00152	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—ovarian cancer	0.000205	0.00152	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—ovarian cancer	0.000202	0.00149	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000202	0.00546	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000202	0.00546	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Paclitaxel—ovarian cancer	0.000201	0.00148	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000199	0.00147	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—ovarian cancer	0.000199	0.00147	CcSEcCtD
Raltitrexed—FPGS—Disease—XIAP—ovarian cancer	0.000197	0.00533	CbGpPWpGaD
Raltitrexed—Stomatitis—Doxorubicin—ovarian cancer	0.000197	0.00146	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—ovarian cancer	0.000197	0.00145	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000197	0.00531	CbGpPWpGaD
Raltitrexed—Conjunctivitis—Doxorubicin—ovarian cancer	0.000196	0.00145	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—RBL2—ovarian cancer	0.000196	0.00529	CbGpPWpGaD
Raltitrexed—Sweating—Doxorubicin—ovarian cancer	0.000194	0.00143	CcSEcCtD
Raltitrexed—Abdominal pain—Paclitaxel—ovarian cancer	0.000193	0.00142	CcSEcCtD
Raltitrexed—Body temperature increased—Paclitaxel—ovarian cancer	0.000193	0.00142	CcSEcCtD
Raltitrexed—FPGS—Disease—SMARCA4—ovarian cancer	0.000192	0.00519	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000188	0.00139	CcSEcCtD
Raltitrexed—FPGS—Disease—EREG—ovarian cancer	0.000188	0.00507	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000187	0.00506	CbGpPWpGaD
Raltitrexed—Dyspepsia—Docetaxel—ovarian cancer	0.000182	0.00134	CcSEcCtD
Raltitrexed—Decreased appetite—Docetaxel—ovarian cancer	0.00018	0.00133	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—ovarian cancer	0.000177	0.00131	CcSEcCtD
Raltitrexed—Pain—Docetaxel—ovarian cancer	0.000177	0.00131	CcSEcCtD
Raltitrexed—Arrhythmia—Epirubicin—ovarian cancer	0.000175	0.00129	CcSEcCtD
Raltitrexed—Asthenia—Paclitaxel—ovarian cancer	0.000175	0.00129	CcSEcCtD
Raltitrexed—Alopecia—Epirubicin—ovarian cancer	0.000173	0.00128	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—MYC—ovarian cancer	0.000173	0.00467	CbGpPWpGaD
Raltitrexed—Pruritus—Paclitaxel—ovarian cancer	0.000172	0.00127	CcSEcCtD
Raltitrexed—Feeling abnormal—Docetaxel—ovarian cancer	0.00017	0.00126	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000169	0.00125	CcSEcCtD
Raltitrexed—FPGS—Metabolism—YAP1—ovarian cancer	0.000169	0.00456	CbGpPWpGaD
Raltitrexed—Dysgeusia—Epirubicin—ovarian cancer	0.000167	0.00124	CcSEcCtD
Raltitrexed—Diarrhoea—Paclitaxel—ovarian cancer	0.000167	0.00123	CcSEcCtD
Raltitrexed—FPGS—Disease—FASN—ovarian cancer	0.000164	0.00443	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDKN1B—ovarian cancer	0.000164	0.00443	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PARP1—ovarian cancer	0.000163	0.00442	CbGpPWpGaD
Raltitrexed—Body temperature increased—Docetaxel—ovarian cancer	0.000163	0.00121	CcSEcCtD
Raltitrexed—Abdominal pain—Docetaxel—ovarian cancer	0.000163	0.00121	CcSEcCtD
Raltitrexed—TYMS—Metabolism—NME2—ovarian cancer	0.000163	0.0044	CbGpPWpGaD
Raltitrexed—Arrhythmia—Doxorubicin—ovarian cancer	0.000162	0.0012	CcSEcCtD
Raltitrexed—Alopecia—Doxorubicin—ovarian cancer	0.00016	0.00118	CcSEcCtD
Raltitrexed—Ill-defined disorder—Epirubicin—ovarian cancer	0.000158	0.00117	CcSEcCtD
Raltitrexed—Anaemia—Epirubicin—ovarian cancer	0.000158	0.00117	CcSEcCtD
Raltitrexed—FPGS—Disease—SLC2A1—ovarian cancer	0.000156	0.00421	CbGpPWpGaD
Raltitrexed—Vomiting—Paclitaxel—ovarian cancer	0.000155	0.00114	CcSEcCtD
Raltitrexed—Dysgeusia—Doxorubicin—ovarian cancer	0.000155	0.00114	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000154	0.00416	CbGpPWpGaD
Raltitrexed—Malaise—Epirubicin—ovarian cancer	0.000154	0.00114	CcSEcCtD
Raltitrexed—Rash—Paclitaxel—ovarian cancer	0.000154	0.00114	CcSEcCtD
Raltitrexed—Dermatitis—Paclitaxel—ovarian cancer	0.000154	0.00113	CcSEcCtD
Raltitrexed—Leukopenia—Epirubicin—ovarian cancer	0.000153	0.00113	CcSEcCtD
Raltitrexed—Headache—Paclitaxel—ovarian cancer	0.000153	0.00113	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.00015	0.00406	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—ovarian cancer	0.000149	0.0011	CcSEcCtD
Raltitrexed—Asthenia—Docetaxel—ovarian cancer	0.000148	0.0011	CcSEcCtD
Raltitrexed—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000147	0.00108	CcSEcCtD
Raltitrexed—Pruritus—Docetaxel—ovarian cancer	0.000146	0.00108	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—ovarian cancer	0.000146	0.00108	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000146	0.00394	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000146	0.00394	CbGpPWpGaD
Raltitrexed—Arthralgia—Epirubicin—ovarian cancer	0.000145	0.00107	CcSEcCtD
Raltitrexed—Nausea—Paclitaxel—ovarian cancer	0.000145	0.00107	CcSEcCtD
Raltitrexed—Methotrexate—ABCB1—ovarian cancer	0.000144	0.0209	CrCbGaD
Raltitrexed—Discomfort—Epirubicin—ovarian cancer	0.000144	0.00106	CcSEcCtD
Raltitrexed—Malaise—Doxorubicin—ovarian cancer	0.000142	0.00105	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—ovarian cancer	0.000141	0.00104	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—ovarian cancer	0.000141	0.00104	CcSEcCtD
Raltitrexed—Oedema—Epirubicin—ovarian cancer	0.000139	0.00103	CcSEcCtD
Raltitrexed—Infection—Epirubicin—ovarian cancer	0.000138	0.00102	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000138	0.00374	CbGpPWpGaD
Raltitrexed—Cough—Doxorubicin—ovarian cancer	0.000138	0.00102	CcSEcCtD
Raltitrexed—FPGS—Metabolism—FASN—ovarian cancer	0.000137	0.00371	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Epirubicin—ovarian cancer	0.000136	0.00101	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC5A5—ovarian cancer	0.000135	0.00365	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Epirubicin—ovarian cancer	0.000135	0.000995	CcSEcCtD
Raltitrexed—Arthralgia—Doxorubicin—ovarian cancer	0.000134	0.000994	CcSEcCtD
Raltitrexed—Discomfort—Doxorubicin—ovarian cancer	0.000133	0.000982	CcSEcCtD
Raltitrexed—Anorexia—Epirubicin—ovarian cancer	0.000133	0.000981	CcSEcCtD
Raltitrexed—FPGS—Disease—PPP2R1A—ovarian cancer	0.000133	0.00358	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000132	0.00356	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—ovarian cancer	0.000132	0.00356	CbGpPWpGaD
Raltitrexed—Vomiting—Docetaxel—ovarian cancer	0.000131	0.00097	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC2A1—ovarian cancer	0.000131	0.00353	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—SKP2—ovarian cancer	0.00013	0.00352	CbGpPWpGaD
Raltitrexed—Rash—Docetaxel—ovarian cancer	0.00013	0.000962	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—ovarian cancer	0.00013	0.000961	CcSEcCtD
Raltitrexed—Headache—Docetaxel—ovarian cancer	0.000129	0.000956	CcSEcCtD
Raltitrexed—Oedema—Doxorubicin—ovarian cancer	0.000129	0.000952	CcSEcCtD
Raltitrexed—Infection—Doxorubicin—ovarian cancer	0.000128	0.000946	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000127	0.000938	CcSEcCtD
Raltitrexed—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000126	0.000933	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—ovarian cancer	0.000126	0.00339	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP1B1—ovarian cancer	0.000125	0.00338	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000125	0.000921	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000123	0.00334	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—ovarian cancer	0.000123	0.000908	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—ovarian cancer	0.000123	0.000907	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—ovarian cancer	0.000123	0.000906	CcSEcCtD
Raltitrexed—Decreased appetite—Epirubicin—ovarian cancer	0.000121	0.000895	CcSEcCtD
Raltitrexed—Constipation—Epirubicin—ovarian cancer	0.000119	0.00088	CcSEcCtD
Raltitrexed—Pain—Epirubicin—ovarian cancer	0.000119	0.00088	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000117	0.000868	CcSEcCtD
Raltitrexed—Feeling abnormal—Epirubicin—ovarian cancer	0.000115	0.000848	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000114	0.000842	CcSEcCtD
Raltitrexed—Dyspepsia—Doxorubicin—ovarian cancer	0.000113	0.000838	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000113	0.00306	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—ovarian cancer	0.000112	0.000828	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000112	0.00302	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PPP2R1A—ovarian cancer	0.000111	0.003	CbGpPWpGaD
Raltitrexed—Pain—Doxorubicin—ovarian cancer	0.00011	0.000815	CcSEcCtD
Raltitrexed—Constipation—Doxorubicin—ovarian cancer	0.00011	0.000815	CcSEcCtD
Raltitrexed—Abdominal pain—Epirubicin—ovarian cancer	0.00011	0.000814	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—ovarian cancer	0.00011	0.000814	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CHEK2—ovarian cancer	0.000107	0.00288	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Doxorubicin—ovarian cancer	0.000106	0.000785	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.000106	0.00286	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000105	0.000779	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000105	0.00285	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—ovarian cancer	0.000105	0.00285	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYTB—ovarian cancer	0.000105	0.00283	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000105	0.00283	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ABCB1—ovarian cancer	0.000103	0.00279	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000103	0.00277	CbGpPWpGaD
Raltitrexed—Body temperature increased—Doxorubicin—ovarian cancer	0.000102	0.000753	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—ovarian cancer	0.000102	0.000753	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TYMS—ovarian cancer	0.000101	0.00274	CbGpPWpGaD
Raltitrexed—Asthenia—Epirubicin—ovarian cancer	0.0001	0.000739	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	9.99e-05	0.0027	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND2—ovarian cancer	9.99e-05	0.0027	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BRCA1—ovarian cancer	9.99e-05	0.0027	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	9.9e-05	0.00267	CbGpPWpGaD
Raltitrexed—Pruritus—Epirubicin—ovarian cancer	9.86e-05	0.000728	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	9.78e-05	0.00264	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CAV1—ovarian cancer	9.74e-05	0.00263	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	9.65e-05	0.00261	CbGpPWpGaD
Raltitrexed—Diarrhoea—Epirubicin—ovarian cancer	9.53e-05	0.000704	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	9.42e-05	0.00255	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	9.26e-05	0.0025	CbGpPWpGaD
Raltitrexed—Asthenia—Doxorubicin—ovarian cancer	9.25e-05	0.000683	CcSEcCtD
Raltitrexed—FPGS—Disease—IL6ST—ovarian cancer	9.24e-05	0.0025	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPP1CC—ovarian cancer	9.16e-05	0.00248	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—BRIP1—ovarian cancer	9.16e-05	0.00248	CbGpPWpGaD
Raltitrexed—Pruritus—Doxorubicin—ovarian cancer	9.12e-05	0.000674	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—BRCA2—ovarian cancer	9.03e-05	0.00244	CbGpPWpGaD
Raltitrexed—FPGS—Disease—APC—ovarian cancer	8.88e-05	0.0024	CbGpPWpGaD
Raltitrexed—Vomiting—Epirubicin—ovarian cancer	8.86e-05	0.000655	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—ovarian cancer	8.82e-05	0.000652	CcSEcCtD
Raltitrexed—Rash—Epirubicin—ovarian cancer	8.78e-05	0.000649	CcSEcCtD
Raltitrexed—Dermatitis—Epirubicin—ovarian cancer	8.78e-05	0.000648	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CCNE1—ovarian cancer	8.75e-05	0.00236	CbGpPWpGaD
Raltitrexed—Headache—Epirubicin—ovarian cancer	8.73e-05	0.000645	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	8.71e-05	0.00235	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	8.64e-05	0.00233	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—ovarian cancer	8.28e-05	0.000611	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	8.24e-05	0.00223	CbGpPWpGaD
Raltitrexed—Vomiting—Doxorubicin—ovarian cancer	8.2e-05	0.000606	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CAV1—ovarian cancer	8.16e-05	0.0022	CbGpPWpGaD
Raltitrexed—Rash—Doxorubicin—ovarian cancer	8.13e-05	0.000601	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—ovarian cancer	8.12e-05	0.0006	CcSEcCtD
Raltitrexed—Headache—Doxorubicin—ovarian cancer	8.08e-05	0.000597	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.02e-05	0.00217	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	7.84e-05	0.00212	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	7.84e-05	0.00212	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CD—ovarian cancer	7.8e-05	0.00211	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BIRC5—ovarian cancer	7.73e-05	0.00209	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—ovarian cancer	7.66e-05	0.000566	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—TERT—ovarian cancer	7.48e-05	0.00202	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CG—ovarian cancer	7.43e-05	0.00201	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	7.41e-05	0.002	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB2—ovarian cancer	6.89e-05	0.00186	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	6.81e-05	0.00184	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—ovarian cancer	6.8e-05	0.00184	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—ovarian cancer	6.8e-05	0.00184	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.58e-05	0.00178	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CD—ovarian cancer	6.53e-05	0.00177	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1B—ovarian cancer	6.38e-05	0.00172	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—ovarian cancer	6.32e-05	0.00171	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—YAP1—ovarian cancer	6.15e-05	0.00166	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—ovarian cancer	6.03e-05	0.00163	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—ovarian cancer	5.88e-05	0.00159	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—ovarian cancer	5.78e-05	0.00156	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CB—ovarian cancer	5.7e-05	0.00154	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.56e-05	0.0015	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—ovarian cancer	5.26e-05	0.00142	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—ovarian cancer	5.24e-05	0.00142	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.07e-05	0.00137	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK3—ovarian cancer	5.02e-05	0.00136	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FASN—ovarian cancer	5.01e-05	0.00135	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC5A5—ovarian cancer	4.93e-05	0.00133	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—ovarian cancer	4.92e-05	0.00133	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—ovarian cancer	4.88e-05	0.00132	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	4.84e-05	0.00131	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK1—ovarian cancer	4.78e-05	0.00129	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—ovarian cancer	4.78e-05	0.00129	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A1—ovarian cancer	4.76e-05	0.00129	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1B1—ovarian cancer	4.56e-05	0.00123	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—ovarian cancer	4.53e-05	0.00123	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—ovarian cancer	4.51e-05	0.00122	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—ovarian cancer	4.33e-05	0.00117	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—ovarian cancer	4.15e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPP2R1A—ovarian cancer	4.05e-05	0.00109	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	3.99e-05	0.00108	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	3.88e-05	0.00105	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—ovarian cancer	3.84e-05	0.00104	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	3.8e-05	0.00103	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—ovarian cancer	3.76e-05	0.00102	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—ovarian cancer	3.67e-05	0.000992	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK3—ovarian cancer	3.57e-05	0.000964	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—ovarian cancer	3.47e-05	0.000938	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—ovarian cancer	3.47e-05	0.000937	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK1—ovarian cancer	3.39e-05	0.000917	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—ovarian cancer	3.39e-05	0.000915	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CAV1—ovarian cancer	2.97e-05	0.000804	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—ovarian cancer	2.85e-05	0.00077	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—ovarian cancer	2.84e-05	0.000766	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—ovarian cancer	2.71e-05	0.000732	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—ovarian cancer	2.38e-05	0.000643	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—ovarian cancer	2.08e-05	0.000561	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—ovarian cancer	1.79e-05	0.000485	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—ovarian cancer	1.27e-05	0.000342	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—ovarian cancer	1.03e-05	0.000279	CbGpPWpGaD
